FCEL Stock Recovers After the Recent Slump, Still Down 45% in a Week
FCEL stock is rebounding this morning after falling as much as 45% over the past week following disappointing earnings from FuelCell Energy Inc (NASDAQ:FCEL). Over the course of the past few months, FuelCell has emerged ... [Read]
PLUG Stock Extends Rally on Aggressive Business Planning
PLUG stock is trading higher this morning after Plug Power Inc (NASDAQ:PLUG) said the company is planning to hire 50 people in 2020 and recently hired a new vice president of human resources and a ... [Read]
FCEL Stock Corrects After Disappointing Q4 Results
Over the past year or so, FuelCell Energy Inc (NASDAQ:FCEL) managed to make a remarkable turnaround in its business, which led to an impressive rally in its stock. However, FCEL stock suffered a significant fall ... [Read]
GNPX Stock Quadruples on FDA Fast Track Status for Oncoprex Therapy
In a new development that has come as a significant boost for GNPX stock, Genprex Inc (NASDAQ:GNPX) today announced that one of its products has been awarded a fast track designation by the United States ... [Read]
NVAX Stock Soars 44% in a Week on Bullish Sentiment
When a pharmaceutical or biotech company manages to get a highly positive update with regards to one of its products in development, then the stock price generally moves in the right direction. That is what ... [Read]
CETX Stock Soars 120% in 2 Sessions on Multiple Pieces of News
CETX stock has soared over 120% in the past two trading sessions after Cemtrex Inc (NASDAQ:CETX) announced that it had received a new $700,000 contract in the Advanced Technology segment. Moreover, on Thursday, the company’s ... [Read]
MNI Stock Rockets 388% After Announcing Pension Deal
MNI stock is the biggest gainer on Thursday and jumped 388% after McClatchy Co (NYSE:MNI) announced the signing of a Standstill Agreement with the Pension Benefit Guaranty Corporation (PBGC). The company had skipped a $12 ... [Read]
CLVS Stock Rockets 20% as FDA Grants Priority Review to Rubraca
CLVS stock is trading sharply higher this morning after the FDA has accepted Clovis Oncology’s (NASDAQ:CLVS) supplemental marketing application seeking approval to use Rubraca (rucaparib). Major News In a new development that has come as ... [Read]
GameStop Disappointing Guidance Rattles GME Stock: Key Factors
GME stock sentiments could turn from bad to worse after GameStop Corp. (NYSE:GME), video-game retailer, lowered its guidance for the year, following a disappointing holiday sales season. A confirmation that full-year sales could drop 21% ... [Read]
DARE Stock Soars 125% on Licensing Deal with Bayer
When a relatively small company signs a significant deal with one of the biggest companies in the world, then the former’s stock generally soars substantially. That is what happened with DARE stock this morning after ... [Read]